• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重对溃疡性结肠炎严重程度及临床病程的影响。

The effect of body weight on the severity and clinical course of ulcerative colitis.

作者信息

Stabroth-Akil Denia, Leifeld Ludger, Pfützer Roland, Morgenstern Julia, Kruis Wolfgang

机构信息

Department of Internal Medicine Gastroenterology, Evangelisches Krankenhaus Kalk, Teaching hospital of the University of Cologne, Buchforststrasse 2, 51103, Cologne, Germany.

出版信息

Int J Colorectal Dis. 2015 Feb;30(2):237-42. doi: 10.1007/s00384-014-2051-3. Epub 2014 Nov 14.

DOI:10.1007/s00384-014-2051-3
PMID:25392256
Abstract

PURPOSE

Obesity is a risk factor for inflammatory diseases such as nonalcoholic steatohepatitis, pancreatitis, and Crohn's disease. The effect of being overweight or obese on the severity and clinical course of ulcerative colitis (UC) was assessed in a retrospective analysis of data from 2000-2006.

METHODS

Two hundred and two consecutive UC patients were categorized according to body mass index (BMI). Patient and disease characteristics were compared between BMI categories using chi-square or Kruskal-Wallis tests. The percentage of patients with active UC, complications, steroid therapy, or immunosuppressive therapy was calculated for each group, and matched pair analyses were performed.

RESULTS

Ten patients (5%) were underweight, 111 (55%) were normal weight, 54 (26.7%) were overweight, and 27 (13.4%) were obese. Pancolitis was inversely related to weight. BMI was also inversely correlated to disease severity, with a significantly smaller proportion of years with chronic active disease among overweight subjects versus normal-weight subjects (17.6 versus 23.9%, p = 0.05). More overweight than normal-weight patients had no chronic active disease in any year (66 versus 49%, p = 0.06), and the proportion of years with disease complications was higher in normal weight than in overweight subjects (1.8 versus 0.4%, p = 0.08). Disease activity during 2000-2006 was higher for underweight versus normal-weight patients, and only 20% of underweight subjects had no hospital admission compared to 80% of normal-weight patients (p = 0.07).

CONCLUSIONS

This first study to explore the influence of obesity on UC showed that high BMI had rather a favorable effect on the prognosis, whereas low BMI pointed to a more severe course of the disease.

摘要

目的

肥胖是非酒精性脂肪性肝炎、胰腺炎和克罗恩病等炎症性疾病的危险因素。通过对2000年至2006年数据的回顾性分析,评估超重或肥胖对溃疡性结肠炎(UC)严重程度和临床病程的影响。

方法

根据体重指数(BMI)对202例连续的UC患者进行分类。使用卡方检验或克鲁斯卡尔-沃利斯检验比较BMI类别之间的患者和疾病特征。计算每组中活动性UC、并发症、类固醇治疗或免疫抑制治疗患者的百分比,并进行配对分析。

结果

10例患者(5%)体重过轻,111例(55%)体重正常,54例(26.7%)超重,27例(13.4%)肥胖。全结肠炎与体重呈负相关。BMI也与疾病严重程度呈负相关,超重受试者中慢性活动性疾病的年比例明显低于正常体重受试者(17.6%对23.9%,p = 0.05)。超重患者在任何一年中无慢性活动性疾病的比例高于正常体重患者(66%对49%,p = 0.06),正常体重患者疾病并发症的年比例高于超重受试者(1.8%对0.4%,p = 0.08)。2000年至2006年期间,体重过轻患者的疾病活动度高于正常体重患者,体重过轻的受试者中只有20%未住院,而正常体重患者为80%(p = 0.07)。

结论

这项首次探索肥胖对UC影响的研究表明,高BMI对预后有较好的影响,而低BMI则表明疾病病程更严重。

相似文献

1
The effect of body weight on the severity and clinical course of ulcerative colitis.体重对溃疡性结肠炎严重程度及临床病程的影响。
Int J Colorectal Dis. 2015 Feb;30(2):237-42. doi: 10.1007/s00384-014-2051-3. Epub 2014 Nov 14.
2
BODY COMPOSITION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS.克罗恩病和溃疡性结肠炎患者的身体组成
Arq Gastroenterol. 2017 Apr-Jun;54(2):109-114. doi: 10.1590/S0004-2803.201700000-02. Epub 2017 Mar 16.
3
Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis?肥胖是否会影响溃疡性结肠炎患者艰难梭菌感染的风险?
Dig Dis Sci. 2018 Sep;63(9):2445-2450. doi: 10.1007/s10620-018-5108-2. Epub 2018 May 19.
4
Nutritional status of children with inflammatory bowel disease in Saudi Arabia.沙特阿拉伯炎症性肠病患儿的营养状况。
World J Gastroenterol. 2016 Feb 7;22(5):1854-8. doi: 10.3748/wjg.v22.i5.1854.
5
[Body mass index and cancer incidence:a prospective cohort study in northern China].[体重指数与癌症发病率:中国北方的一项前瞻性队列研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6.
6
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
7
Overweight and obesity in children with newly diagnosed inflammatory bowel disease.新诊断炎症性肠病患儿的超重与肥胖
Adv Med Sci. 2016 Mar;61(1):28-31. doi: 10.1016/j.advms.2015.07.004. Epub 2015 Aug 8.
8
High and low body mass index may predict severe disease course in children with inflammatory bowel disease.高体重指数和低体重指数可能预示炎症性肠病患儿的病情严重。
Scand J Gastroenterol. 2018 Jun;53(6):708-713. doi: 10.1080/00365521.2018.1464595. Epub 2018 Apr 24.
9
What role does body mass index play in hospital admission rates from the pediatric emergency department?体重指数在儿科急诊科的住院率中起什么作用?
Pediatr Emerg Care. 2013 Sep;29(9):974-8. doi: 10.1097/PEC.0b013e3182a21a23.
10
Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.西班牙西北部城乡及沿海/内陆环境对炎症性肠病患者患病率、表型及临床病程的影响:一项横断面研究
Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1030-7. doi: 10.1097/MEG.0000000000000395.

引用本文的文献

1
Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications.肥胖介导的炎症及其对炎症性肠病的影响:病理生理学、临床影响及治疗意义
Biomolecules. 2025 Aug 18;15(8):1185. doi: 10.3390/biom15081185.
2
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation.IBD中的GLP-1受体激动剂:探索代谢与炎症的交叉点
Front Immunol. 2025 Jul 15;16:1610368. doi: 10.3389/fimmu.2025.1610368. eCollection 2025.
3
Impact of body mass index on clinical outcomes in intestinal Behçet's disease.

本文引用的文献

1
Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.肠系膜脂肪作为 C 反应蛋白的来源和克罗恩病细菌易位的靶点。
Gut. 2012 Jan;61(1):78-85. doi: 10.1136/gutjnl-2011-300370. Epub 2011 Sep 21.
2
Nutritional follow-up of patients with ulcerative colitis during periods of intestinal inflammatory activity and remission.溃疡性结肠炎患者在肠道炎症活动期和缓解期的营养随访。
Arq Gastroenterol. 2010 Jan-Mar;47(1):49-55. doi: 10.1590/s0004-28032010000100009.
3
Obesity and the risk of severe acute pancreatitis.
体重指数对肠道白塞病临床结局的影响。
Korean J Intern Med. 2025 Jul;40(4):606-615. doi: 10.3904/kjim.2024.349. Epub 2025 Jul 1.
4
Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review.炎症性肠病患者的心脏代谢疾病:一项循证综述。
World J Gastroenterol. 2025 Jun 28;31(24):107661. doi: 10.3748/wjg.v31.i24.107661.
5
Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study.肥胖与炎症性肠病较差的临床治疗结果相关:一项荷兰全国性登记研究
Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09052-5.
6
Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease.韩国炎症性肠病患者肥胖的时间趋势及其预后影响
J Gastroenterol. 2025 May;60(5):583-592. doi: 10.1007/s00535-025-02230-2. Epub 2025 Feb 26.
7
Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort.前瞻性多中心队列研究中急性重症溃疡性结肠炎住院患者的预后预测
Inflamm Bowel Dis. 2025 Jun 13;31(6):1548-1555. doi: 10.1093/ibd/izae193.
8
Hepatic Gα13 ablation shifts region-specific colonic inflammatory status by modulating the bile acid synthetic pathway in mice.肝 Gα13 缺失通过调节胆汁酸合成途径改变小鼠结肠特定区域的炎症状态。
Sci Rep. 2024 Aug 23;14(1):19580. doi: 10.1038/s41598-024-70254-4.
9
Impact of Obesity and Metabolic Syndrome on IBD Outcomes.肥胖症和代谢综合征对炎症性肠病结局的影响。
Dig Dis Sci. 2024 Aug;69(8):2741-2753. doi: 10.1007/s10620-024-08504-8. Epub 2024 Jun 12.
10
C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis.C反应蛋白与白蛋白比值及中性粒细胞与白蛋白比值对预测溃疡性结肠炎患者英夫利昔单抗的反应和预后的价值
Front Med (Lausanne). 2024 Mar 12;11:1349070. doi: 10.3389/fmed.2024.1349070. eCollection 2024.
肥胖与重症急性胰腺炎的风险
Minerva Gastroenterol Dietol. 2010 Jun;56(2):169-79.
4
[Percentiles of body mass index of 18-80-year-old German adults based on data from the Second National Nutrition Survey].
Dtsch Med Wochenschr. 2010 Apr;135(17):848-52. doi: 10.1055/s-0030-1253666. Epub 2010 Apr 20.
5
A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland.苏格兰泰赛德地区炎症性肠病患者肥胖症的流行病学简述报告。
Obes Facts. 2009;2(6):370-2. doi: 10.1159/000262276. Epub 2009 Dec 17.
6
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.脂联素失调、脂肪组织炎症与代谢综合征。
Mol Cell Endocrinol. 2010 Jan 15;314(1):1-16. doi: 10.1016/j.mce.2009.07.031. Epub 2009 Aug 12.
7
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.克罗恩病和溃疡性结肠炎在体重指数和初始疾病活动度对硫唑嘌呤反应性的影响方面存在显著差异:来自欧洲多中心 1176 例患者的研究结果。
Dig Dis Sci. 2010 Apr;55(4):1066-78. doi: 10.1007/s10620-009-0846-9. Epub 2009 Jun 10.
8
Obesity increases the risks of diverticulitis and diverticular bleeding.肥胖会增加憩室炎和憩室出血的风险。
Gastroenterology. 2009 Jan;136(1):115-122.e1. doi: 10.1053/j.gastro.2008.09.025. Epub 2008 Sep 25.
9
Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.纤维化的疾病特异性机制:丙型肝炎病毒与非酒精性脂肪性肝炎
Clin Liver Dis. 2008 Nov;12(4):805-24, ix. doi: 10.1016/j.cld.2008.07.003.
10
Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.循环脂肪因子与高胰岛素血症在炎症性肠病中的保护作用
Nutrition. 2009 Feb;25(2):172-81. doi: 10.1016/j.nut.2008.07.020. Epub 2008 Oct 11.